CLIPI Refines Risk Stratification in Advanced Cutaneous Lymphoma
An international study found that CLIPI scores distinguished progression risk and treatment response in advanced mycosis fungoides and Sézary syndrome, improving prognostic discrimination beyond baseline clinical stage.







